A Voltage-Sensitive Ultrasound Enhancing Agent for Myocardial Perfusion Imaging in a Rat Model

Ultrasound Med Biol. 2020 Sep;46(9):2388-2399. doi: 10.1016/j.ultrasmedbio.2020.05.015. Epub 2020 Jun 25.

Abstract

Echocardiographers with specialized expertise sometimes perform myocardial perfusion imaging using U.S. Food and Drug Administration-approved microbubbles in an off-label capacity, correlating microbubble replenishment in the near field with blood flow through the myocardium. This study reports the in vivo clinical feasibility of a voltage-sensitive ultrasound enhancing agent (UEA) for myocardial perfusion imaging. Four UEAs were injected into Sprague-Dawley rats while ultrasound images were collected to quantify brightness in the left ventricular (LV) cavity, septal wall, and posterior wall in systole and diastole. Formulation IV, a phase change agent nested within a negatively charged phospholipid bilayer, increased the tissue-to-cavity ratio in both systole and diastole in the septal wall, 6 dB, and in the posterior wall, 5 dB, while leaving the LV cavity at baseline. This outcome improves the signal of the myocardium relative to the LV cavity and shows promise as a myocardial perfusion UEA.

Keywords: Echocardiography; Nesting; Perfluorocarbon; Perfusion; Ultrasound.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Echocardiography / methods*
  • Electricity*
  • Feasibility Studies
  • Female
  • Image Enhancement / methods*
  • Microbubbles*
  • Models, Animal
  • Myocardial Perfusion Imaging / methods*
  • Rats
  • Rats, Sprague-Dawley